Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
DeFi Crypto Mutuum Finance Prepares for 20% Price Increase as Phase 6 Nears Completion
-
New Crypto Coin Mutuum Finance Nears 100% of Phase 6 Allocation as Price Shift Approaches
-
Scatec starts commercial operation at Grootfontein solar power plant in South Africa
-
Cardinal Point Wealth Management Releases New 2025 Cross-Border Retirement Guide for High-Net-Worth Families
-
Toripalimab Presents Long-Term Survival Benefits as 1st-line Treatment for Advanced Nasopharyngeal Carcinoma and Esophageal Squamous Cell Carcinoma Patients
-
Cerevance Showcases Positive Phase 2 Results Demonstrating Significant Reduction in OFF Time with Solengepras as an Adjunctive Treatment in Parkinson’s Disease
-
ORIC® Pharmaceuticals Presents Potential Best-in-Class Profile for Enozertinib with Robust Systemic and CNS Activity in 1L and 2L NSCLC Patients with EGFR Exon 20 Mutations at the ESMO Asia Congress
-
Copper Quest Closes $1,927,000 Private Placement
-
AB Value Partners, L.P. Announces Proposed Settlement of Stockholder Class Action on Behalf of Former Holders of Orbit/FR, Inc. Common Stock - ORFR
-
HNI Corporation Announces Expiration and Final Results of Exchange Offer
-
Guardian Capital Announces Estimated 2025 Annual Non-Cash Distributions for Guardian Capital ETFs
-
Webus International Limited Issues Clarification on Previous Announcement Related to Expedia Group
-
LocationSync Releases New Consumer Insights Highlighting Nationwide Shift Toward Comfort-Driven Home Upgrades
-
Colabor Group Announces Resignation of Director
-
Sable Announces Adoption of New Equity Incentive Plan
-
Skyharbour Closes $2.1 Million Private Placement of Flow-Through Shares
-
Connell Consulting Business Agency, LLC makes lobbying debut addressing Personal Injury Protection (PIP) loophole
-
Rocket Doctor Announces Granting of RSUs and Options and a Change of CFO
-
Fly-E Group, Inc. Announces Receipt of Delinquency Notice from Nasdaq Regarding Delayed Form 10-Q
-
Clearmind Medicine Announces Receipt of Nasdaq Minimum Bid Price Notification
-
CyberloQ Technologies, Inc to Present at the Small Cap Growth Virtual Investor Conference December 9th
-
Children’s National Hospital welcomes First Lady Melania Trump for holiday visit
-
USCB Financial Holdings, Inc. Portfolio Loss Restructuring
-
USCB Financial Holdings, Inc. Portfolio Loss Restructuring
-
Parsons Selected As Lead Designer For $441 Million I-70 Rocheport To Columbia Design-Build Project
-
Global Mofy AI Limited Announces US$4.8 Million Private Placement Financing
-
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Quanex Building Products Declares Quarterly Dividend
-
Bimergen Energy Announces Uplist to the NYSE American Stock Exchange with Concurrent Offering
-
Omega Flex, Inc. Announces Regular Quarterly Dividend for the Fourth Quarter 2025
-
ProCap BTC and Columbus Circle Capital Corp I Complete Business Combination
-
Performance Shipping Inc. Provides Update on Potential Forward Sale Agreement for M/T P. Sophia
-
Sunrise Signs 5,000-Ton Anode Material Supply Contract With Pylontech, Expanding Into the European Residential Energy Storage Market
-
Regentis Biomaterials Ltd. Announces Closing of Initial Public Offering
-
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Spyre Therapeutics Announces Grants of Inducement Awards
-
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Meihua International Medical Technologies Co., Ltd. Received Nasdaq Delisting Notice
-
Pheton Holdings Ltd Announces Closing of Share Acquisition with iTonic Corporation
-
Bahamasair and Emirates Partnership Activated, Offering Direct Connections to Nassau and Freeport
-
Hingham Savings Authorizes Stock Repurchase Program
-
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Kymera Therapeutics to Announce KT-621 BroADen Phase 1b Atopic Dermatitis Trial Results on December 8, 2025
-
Announcement relating to despatch of Rule 15 proposal
-
Parsons Selected for $1B Sound Transit MATOC to Support Regional Transit Expansion
-
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Emerita Receives Official Court Resolution in Aznalcóllar Trial
-
Powering Brighter Futures: AEP Texas Foundation Awards $75,000 for Youth Art Education in Port Aransas
-
Humanoid Global Welcomes Marc Theermann, Chief Strategy Officer of Boston Dynamics to its Technical Advisory Committee
